Suppr超能文献

[瞳孔后固定型虹膜爪式人工晶状体的二期植入]

[Secondary implantation of retropupillary fixated iris-claw intraocular lenses].

作者信息

Paun B, Schüler A

机构信息

Bergman Clinics Augenklinik Universitätsallee, Parkallee 301, 28213, Bremen, Deutschland.

出版信息

Ophthalmologie. 2023 Feb;120(2):184-190. doi: 10.1007/s00347-022-01714-3. Epub 2022 Aug 26.

Abstract

BACKGROUND

There is no standard for the treatment of functional aphakia in cases with a compromised capsular system. Retropupillary fixation of an Artisan iris-claw IOL ("Intraokularlinse") is one of the established procedures.

OBJECTIVE

Aim of this study was the evaluation of indications, visual and refractive long-term results and complication rates after retropupillary implantation of an iris-claw lens.

MATERIAL AND METHODS

This retrospective study comprised 366 eyes that received a retropupillary Artisan intraocular lens (IOL) in a single center between January 2009 and December 2019. The mean follow-up period was 249 days (8 months) ±516 days.

RESULTS

IOL dislocation (68%) was the most common reason for a retropupillary iris-claw implantation. Previous vitrectomy was a significant preoperative risk factor for IOL dislocation (p = 0.0001). Best corrected visual acuity improved from 0.65 ± 0.64 (logMAR) preoperatively to 0.57 ± 0.51 (logMAR) 4-6 weeks after the surgery. The mean deviation from the planned refraction was +0.40 ± 1.37 dpt and 73% of the patients had a deviation within ±1 dpt of the planned refraction. Relevant postoperative complications during the first 4 weeks were pupillary distortion (42%), ocular hypotony (15%) and transient hyphema (14%). Late complications (≥4 weeks after the surgery) included persistent pupillary distortion (20%), cystoid macular edema (13%) and iris-claw disenclavation (6%).

CONCLUSION

The retropupillary Artisan implantation is an efficient method for treating aphakia without capsular support and provides good visual and refractive results with an acceptable surgical risk profile.

摘要

背景

对于囊膜系统受损的无晶状体眼病例,目前尚无功能性无晶状体眼的治疗标准。Artisan虹膜爪型人工晶状体(“眼内晶状体”)的瞳孔后固定是既定的手术方法之一。

目的

本研究的目的是评估虹膜爪型晶状体瞳孔后植入后的适应症、视觉和屈光长期结果以及并发症发生率。

材料与方法

这项回顾性研究纳入了2009年1月至2019年12月在单一中心接受瞳孔后Artisan人工晶状体(IOL)植入的366只眼。平均随访期为249天(8个月)±516天。

结果

人工晶状体脱位(68%)是瞳孔后虹膜爪植入最常见的原因。既往玻璃体切除术是人工晶状体脱位的一个重要术前危险因素(p = 0.0001)。最佳矫正视力从术前的0.65±0.64(logMAR)提高到术后4 - 6周的0.57±0.51(logMAR)。与计划屈光度的平均偏差为+0.40±1.37屈光度,73%的患者偏差在计划屈光度的±1屈光度范围内。术后前4周的相关并发症包括瞳孔变形(42%)、低眼压(15%)和短暂性前房积血(14%)。晚期并发症(术后≥4周)包括持续性瞳孔变形(20%)、黄斑囊样水肿(13%)和虹膜爪脱离(6%)。

结论

瞳孔后Artisan人工晶状体植入是治疗无囊膜支持的无晶状体眼的有效方法,能提供良好的视觉和屈光效果,且手术风险可接受。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验